Yo-Bio

Father of two & husband of one. US&EU. Engineer & science lover. Biotech & Generics. Protalix black belt.

[Yo-Bio @BNNIYU]

$TEVA and $SNY announce strategic collaboration for anti-TL1A therapy.
TEVA will receive an upfront payment of €469 million ($500 million) and up to €940 million ($1 billion) in development and launch milestones.

[Yo-Bio @BNNIYU]

Protalix new Corporate Presentation not put the exact milestone numbers from Chiesi but should be not less than $50M (For 2Q'25 with 0 Debt and 0 cash).
I believe that the number will be closer to $80M for FDA and EMA approval alone.
https://t.co/exy6OwJort
$PLX

[Yo-Bio @BNNIYU]

Protalix get European Commission approval of Elfabrio (pegunigalsidase alfa) for the treatment of Fabry Disease.
Was a long road. The future is bright for this great company. $PLX https://t.co/HDmXSot0vz

[Yo-Bio @BNNIYU]

@hasolidit מעדיף אותו בחיק הימין בו אוכל לצמצם את הוצאותיו ונזקיו מאשר לגרום לו לעבור צד פוליטי, שיהפוך אותו ברגע אחד לצדיק טהור וקול חשוב בממשלה, ולספוג הוצאות ונזקים שאני בכלל לא מסוגל לאמוד.

[Yo-Bio @BNNIYU]

@TheRealYield נשמע כמו תחילתו של חשבון נפש.

[Yo-Bio @BNNIYU]

@zerohedge Following you from israel. Twitter attached warning notification to your tweet in Hebrew. “Such conversations can be intense״. You probably crossed the Principles of Newspeak..

[Yo-Bio @BNNIYU]

@amit_segal זה בסדר.. בג״ץ בטוח יפסול את החקיקה הזו

[Yo-Bio @BNNIYU]

@stirtingsup @stirtingsup Thanks for your concern! I’m great. Just intense time at my work. ❤️

[Yo-Bio @BNNIYU]

@Intel_Sky Only if your mother onboard

[Yo-Bio @BNNIYU]

@rubih67 גבוהים בחצי ס״מ מהמפלס לפני שנה בדיוק

[Yo-Bio @BNNIYU]

@Roy_Iddan זכר מסמך לברכה

[Yo-Bio @BNNIYU]

@DdongISR כשליאת בן ארי מסבירה שיש אישור

[Yo-Bio @BNNIYU]

$PLX 52 week high for the first time since 2010.

[Yo-Bio @BNNIYU]

@AyalaHasson ההפסד שלנו. הרווח של הפרקליטות.

[Yo-Bio @BNNIYU]

$TEVA selling OTC brand portfolio to Karo pharma for $100M.

The brands generated sales of $42M in 2020 on a global basis.
https://t.co/XZBxxV5EZz

[Yo-Bio @BNNIYU]

$RDY with CRL's at the earning call. second for Copaxone. $TEVA

[Yo-Bio @BNNIYU]

Lyso-Gb3 levels will be associated with improved long-term outcome.
Great article. strongly support Protalix path to FDA approval and reveal how bad is the Fabry SOC (Fabrazyme, Replagal)
$PLX
https://t.co/nMCKcVKO3W

[Yo-Bio @BNNIYU]

$PLX update.
the FDA update the "Surrogate Endpoints of Drug Approval or Licensure".
and one of the only updates is for Fabry disease for Accelerated approval.
the one that protalix seek: GL-3 inclusion score or plasma GL-3 levels.
https://t.co/Gvvxh7TzUI

[Yo-Bio @BNNIYU]

$TEVA investment in $AMWL now worth ~$500M

[Yo-Bio @BNNIYU]

$TEVA invested $60M in $AMWL back in 2015. after Amwell IPO Teva hold's 5.56% of the company worth $340M.

https://t.co/Etx3xE44yq

[Yo-Bio @BNNIYU]

And now, Aimovig "can cause markedly elevated blood pressure with or without pre-existing hypertension"
$NVS $AMGN $TEVA $LLY $BHVN
https://t.co/n0AnAdN7Cm

[Yo-Bio @BNNIYU]

Aimovig label becoming more and more dirty.
first constipation and now hypertention.

$NVS $AMGN $TEVA $LLY